Joe Rich of Cleveland Clinic Innovations joins other Cleveland area thought leaders to discuss the future of the Cleveland Innovation District.
Cleveland Clinic recognized as one of the most innovative health systems.
Clario and Cleveland Clinic's Cole Eye Institute announce strategic partnership to provide new ophthalmology offerings for clinical trials.
NeuroTherapia, a Cleveland Clinic Innovations portfolio company, has been awarded its second grant from the Alzheimer's Association Part the Cloud program. The grant will fund the clinical development of NTRX-07, a first-of-its-kind drug for Alzheimer's disease (AD) treatment.
Cleveland Clinic invested in the startup company, Floreo who has acquired Autism Eyes, an autism diagnostics and assessment company that Cleveland Clinic spun off in 2019. JD Friedland, Managing Director of Cleveland Clinic Ventures, discusses the significant contributions these companies are making to autism research
Cleveland, OH – Cleveland Clinic Innovations (CCI) proudly announces the launch of its redesigned Inventor Portal, a platform designed to advance the way Cleveland Clinic caregivers engage with Innovations.
Todd Schwarzinger, MBA, Partner at Cleveland Clinic Ventures underscored the role of hospital venture capital arms in aiding healthcare startups.
Geoff Vince, PhD, Executive Director of Cleveland Clinic Innovations, has made significant changes to the organization including a new structure and an increased focus on therapeutics and digital health. Cleveland Clinic Innovations strives to have a balanced portfolio of medical devices, therapeutics and diagnostics, and digital health companies.
Cleveland Clinic Innovations prides itself on fostering new ways to advance patient care.